Indirect evidence indicates that Smad7-induced TGF-β1/Smad signaling impairment reduces the expression of intestinal claudin-4 thereby contributing to the impaired epithelial function seen in IBD patients (Marincola Smith et al., 2021). Here, SMAD7 is linked to inflammatory bowel disease.